Yubin Kang

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman et al. · Leukemia · 2019 · 597 citations

Hematological Malignancy, Oncology, Multiple Myeloma Refractory +5

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2020 · 273 citations

Hematological Malignancy, Bone Marrow Failure, Medicine +10

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Balamayoora Theivanthiran, Kathy S. Evans, Nicholas C. DeVito et al. · Journal of Clinical Investigation · 2020 · 235 citations · Full text

Immunology, Immunotherapy Resistance, Immunotherapeutics +19

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018

Shaji Kumar, Natalie S. Callander, Melissa Alsina et al. · Journal of the National Comprehensive Cancer Network · 2018 · 203 citations · Full text

Hematological Malignancy, Medicine, Hematology +10

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022

Natalie S. Callander, Muhamed Baljević, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2022 · 200 citations

Hematological Malignancy, Nccn Guidelines® Insights, Medicine +11